ORBIMED ADVISORS LLC 13D and 13G filings for Apollomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-15 4:38 pm Sale |
2024-08-13 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 500 0.050% |
-85,655 (-99.42%) |
Filing |
| 2024-05-22 7:32 pm Unchanged |
2024-05-20 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 86,155 7.900% |
0 (Unchanged) |
Filing |
| 2023-11-29 4:20 pm Sale |
2023-11-27 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 86,155 9.600% |
-9,177 (-9.63%) |
Filing |
| 2023-11-20 4:21 pm Sale |
2023-11-16 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 95,332 18.100% |
-67,000 (-41.27%) |
Filing |
| 2023-11-01 5:08 pm Sale |
2023-10-30 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 162,332 18.100% |
-18,105 (-10.03%) |
Filing |
| 2023-10-02 4:41 pm Purchase |
2023-09-29 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 180,436 20.200% |
173,811 (+2623.32%) |
Filing |
| 2023-04-11 7:10 pm Purchase |
2023-03-29 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 6,626 10.300% |
6,626 (New Position) |
Filing |